In the face of a nationwide mental health crisis, CU Anschutz and UCHealth have emerged as national leaders, not only in research and treatment but in forging innovative pathways to bring care to those who need it most. Their partnership is a testament to what’s possible when academic excellence meets clinical innovation—and when both are driven by a shared commitment to healing minds and saving lives.
The University of Colorado Anschutz Medical Campus is at the forefront of developing a robust, diverse and highly skilled mental health workforce to meet the growing needs of communities across Colorado and beyond. Through innovative academic programs, clinical training and interdisciplinary collaboration, CU Anschutz is preparing professionals who are equipped to address mental health, substance use and wellbeing at individual and population levels.
A National Leader in Population Mental Health
Salwa Bamba provides a first-person account of how the generosity of others propelled her success.
Researchers at CU Anschutz’s Gates Institute are exploring early use of a last-resort therapy in patients with an aggressive form of leukemia.
The groundbreaking phase I clinical trial of CAR T-cell therapy is made possible through gifts for health and health care transformations, which totaled $245 million in 2023. Notably, the Gates Frontiers Fund fueled the institute through philanthropic investments, which are expected to grow to $200 million over the next five years. Philanthropy ensures essential cancer research of this magnitude remains in reach.
Dr. Michelle Barron has had a tough three years. When the COVID-19 pandemic was declared a national emergency in the U.S. in March 2020, her job put her on the front lines.
But Barron, the senior medical director of infection prevention and control for UCHealth University of Colorado Hospital, and her team were up for the challenge, drawing on years of experience researching infectious diseases to improve public health outcomes.